
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Pelargonium sidoides is a South African geranium containing active compounds called proanthocyanidins that support respiratory health. The standardized extract EPs 7630 works by enhancing immune cell activity and providing antimicrobial effects against respiratory pathogens.

Reported Benefits (Provisional)
Origin & History

Pelargonium Sidoides, also known as EPs 7630, is a plant native to South Africa. The roots are harvested and processed to create an extract rich in polyphenols and coumarins.
Research Narrative (Provisional)
Clinical trials, including RCTs, have shown its effectiveness in treating acute bronchitis and reducing the severity of cold symptoms. Studies support its role in enhancing respiratory health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains umckalin, a key coumarin compound. - Rich in polyphenolic compounds. - Provides essential oils with therapeutic properties.
Reported Mechanism (Provisional)
EPs 7630 contains proanthocyanidins and other phenolic compounds that stimulate macrophage activity and enhance interferon-beta production. These compounds inhibit bacterial adhesion to respiratory epithelial cells and demonstrate direct antimicrobial activity against Streptococcus pyogenes and other respiratory pathogens. The extract also modulates cytokine production, reducing inflammatory responses while supporting immune function.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving over 2,000 participants demonstrate EPs 7630's efficacy for acute bronchitis and common cold symptoms. Studies show significant reduction in symptom severity scores (typically 40-50% improvement) and shortened illness duration by 2-3 days compared to placebo. Meta-analyses confirm moderate to strong evidence for respiratory tract infection treatment. Most trials used standardized doses of 30-60mg daily for 7-10 days.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







